My watch list  

Eisai Co.

  Eisai Co., Ltd. (エーザイ株式会社 Ēzai Kabushiki-gaisha?) (TYO: 4523) is one of the global-leading pharmaceutical companies, ranking among the top 25. Headquartered in Tokyo, Japan, has some 9000 employees, among them about 1500 in research. Two of the key molecules Eisai developed are donepezil (Aricept) and rabeprazole (Aciphex).

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Eisai_Co.". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE